These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 17362985)
1. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody. Gong X; Feng H; Zhang S; Yu Y; Li J; Wang J; Guo B J Mol Cell Cardiol; 2007 Apr; 42(4):781-91. PubMed ID: 17362985 [TBL] [Abstract][Full Text] [Related]
2. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965 [TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. Liu W; Li WM; Gao C; Sun NL J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301 [TBL] [Abstract][Full Text] [Related]
4. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of experimental autoimmune myocarditis by adenovirus-mediated gene transfer of antisense CIITA. Cai G; Zhang J; Liu L; Shen Q J Mol Cell Cardiol; 2005 Apr; 38(4):593-605. PubMed ID: 15808836 [TBL] [Abstract][Full Text] [Related]
7. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Liu W; Nakamura H; Shioji K; Tanito M; Oka S; Ahsan MK; Son A; Ishii Y; Kishimoto C; Yodoi J Circulation; 2004 Sep; 110(10):1276-83. PubMed ID: 15337697 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Futamatsu H; Suzuki J; Mizuno S; Koga N; Adachi S; Kosuge H; Maejima Y; Hirao K; Nakamura T; Isobe M Circ Res; 2005 Apr; 96(8):823-30. PubMed ID: 15774858 [TBL] [Abstract][Full Text] [Related]
12. Involvement of Sema4A in the progression of experimental autoimmune myocarditis. Makino N; Toyofuku T; Takegahara N; Takamatsu H; Okuno T; Nakagawa Y; Kang S; Nojima S; Hori M; Kikutani H; Kumanogoh A FEBS Lett; 2008 Nov; 582(28):3935-40. PubMed ID: 18977352 [TBL] [Abstract][Full Text] [Related]
13. Quantification and characterization of myosin peptide-specific CD4+ T cells in autoimmune myocarditis. Maier R; Miller S; Kurrer M; Krebs P; de Giuli R; Kremer M; Scandella E; Ludewig B J Immunol Methods; 2005 Sep; 304(1-2):117-25. PubMed ID: 16125195 [TBL] [Abstract][Full Text] [Related]
14. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158 [TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis. Liu X; Zhu X; Wang A; Fan H; Yuan H Int J Cardiol; 2009 Nov; 137(3):282-8. PubMed ID: 19896742 [TBL] [Abstract][Full Text] [Related]
16. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Cruz-Adalia A; Jiménez-Borreguero LJ; Ramírez-Huesca M; Chico-Calero I; Barreiro O; López-Conesa E; Fresno M; Sánchez-Madrid F; Martín P Circulation; 2010 Oct; 122(14):1396-404. PubMed ID: 20855659 [TBL] [Abstract][Full Text] [Related]
17. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Su Z; Sun C; Zhou C; Liu Y; Zhu H; Sandoghchian S; Zheng D; Peng T; Zhang Y; Jiao Z; Wang S; Xu H Eur J Immunol; 2011 Dec; 41(12):3586-95. PubMed ID: 21928275 [TBL] [Abstract][Full Text] [Related]
18. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis]. Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535 [TBL] [Abstract][Full Text] [Related]
19. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation. Futamatsu H; Suzuki J; Koga N; Adachi S; Kosuge H; Maejima Y; Haga T; Hirao K; Horuk R; Isobe M J Mol Cell Cardiol; 2006 Jun; 40(6):853-61. PubMed ID: 16698032 [TBL] [Abstract][Full Text] [Related]
20. The effect of hydrodynamics-based delivery of an IL-13-Ig fusion gene for experimental autoimmune myocarditis in rats and its possible mechanism. Elnaggar R; Hanawa H; Liu H; Yoshida T; Hayashi M; Watanabe R; Abe S; Toba K; Yoshida K; Chang H; Minagawa S; Okura Y; Kato K; Kodama M; Maruyama H; Miyazaki J; Aizawa Y Eur J Immunol; 2005 Jun; 35(6):1995-2005. PubMed ID: 15902684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]